Media Database
>
Meghana Keshavan

Meghana Keshavan

Biotech Reporter, Writer and Correspondent at STAT News

Contact this person
Email address
m*****@*******.comGet email address
Influence score
56
Location
United States
Languages
  • English
Covering topics
  • Biotechnology

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

statnews.com

Sobi bets big on next-gen gout drug

And other biotech news, brought to you by The Readout
statnews.com

FDA scrutiny of infant RSV shots escalates amid turmoil

And more biotech news brought to you by The Readout newsletter
statnews.com

Terns leukemia drug could succeed Novartis blockbuster

Terns leukemia drug could succeed Novartis blockbuster
statnews.com

Early update shows Wave’s RNA drug cut visceral fat

Early update shows Wave’s RNA drug cut visceral fat
statnews.com

Harvard lab hollowed out by Trump cuts

And more biotech news brought to you by The Readout newsletter
statnews.com

New data confirm Novo drug did not slow Alzheimer’s progression

And other biotech news, brought to you by The Readout newsletter
statnews.com

Vinay Prasad’s ‘extraordinary’ memo about vaccine policy

And more biotech news, brought to you by the The Readout newsletter.
statnews.com

Lilly hits trillion-dollar valuation as GLP-1 era peaks

Plus more biotech news brought to you by The Readout
statnews.com

Novo nears release of high-stakes data on Alzheimer’s and GLP-1s

And more biotech news updates, brought to you by The Readout
statnews.com

Vaccine makers have reason for alarm in proposals to reformulate shots

Plus more biotech news, brought to you by The Readout newsletter
statnews.com

European firms raise two big funds for early biotech

And more biotech news brought to you by The Readout
statnews.com

Makary, Prasad outline pathway for bespoke gene therapy

And other biotech news, brought to you by The Readout
statnews.com

Medicaid’s ‘GENEROUS’ pricing may not save states money

Plus more biotech news stories, brought to you by The Readout
statnews.com

Patient with liver damage in Intellia trial dies

And more biotech news stories for the day, brought to you by The Readout
statnews.com

A bet on baldness

Plus more biotech news updates brought to you by The Readout
statnews.com

Recapping this weekend’s explosive allegations at the FDA

George Tidmarsh denied wrongdoing at the FDA and accused senior FDA officials — including CBER chief Vinay Prasad — of wrongdoing
statnews.com

Alnylam raises guidance as sales of heart drug match expectations

And The Readout newsletter discusses the new drug-sales king that toppled Keytruda.
statnews.com

Moderna faces CMV woes — but sees hope in cancer pipeline

With other Readout newsletter updates on the biggest news stories in biotech.
statnews.com

Hiring and drug review slowdown at the FDA

Plus more biotech news, brought to you by The Readout.
statnews.com

Lilly CSO defends hiring of ex-FDA chief Peter Marks

And other biotech news, brought to you by The Readout newsletter.
statnews.com

Novo strikes $2.1 billion deal with Omeros for rare disease drug

And other biotech news updates, brought to you by The Readout.